SA

Suman Agarwal

Active Director Director DIN 07499915
DIN 07499915 First appointment May 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 2 historical roles
Total affiliations 8 Since May 2016
Shareholding value •••• Premium profile

About Suman Agarwal

Data last updated:

Suman Agarwal is a Director at Chandra Laxmi Hospital Private Limited (since 2020), Director at Girdhar Pharmaceuticals Private Limited (since 2018) and Partner at Divri Health And Education Llp (since 2026), and holds 3 more current directorships. The companies operate in Healthcare, Ecommerce and Internet and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹22.19 Cr; the largest is Chandra Laxmi Hospital Private Limited at ₹22.19 Cr (FY 2025). Earlier, Suman Agarwal was a Director at Deepnidhi Medicare Private Limited (2019–2021) and Director at Vee Pee And Associate Pvt Ltd (2016–2017).

DIN 07499915
Primary Designation Director
Industry Healthcare
First Appointment 03 May 2016
Oldest Company Age 23 yrs
Largest company Chandra Laxmi Hospital Private Limited · ₹22.19 Cr (FY 2025)
Combined revenue ₹22.19 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jan 20202003₹22.19 Cr (FY 2025)Active
Director01 Feb 20182007₹30,000 (FY 2025)Active
Partner24 Jan 20262026Active
Partner21 Mar 20252025Active
Drms Hospital Private Limited U85320DL2022PTC395945
Director31 Mar 20222022Active
Designated Partner28 Dec 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Deepnidhi Medicare Private Limited U85100DL2011PTC213425
Director11 Jan 20192011₹2.38 Cr (FY 2024)Active
Vee Pee And Associate Pvt Ltd U74899DL1982PTC014122
Director03 May 20161982₹20,000 (FY 2017)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Drms And Associate Llp
Girdhar Pharmaceuticals Private Limited
Chandra Laxmi Hospital Private Limited
Drms Hospital Private Limited
Premium access

Shareholding and investment profile for Suman Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suman Agarwal

Suman Agarwal currently holds 6 directorships: Chandra Laxmi Hospital Private Limited (Director, since 20 Jan 2020, revenue ₹22.19 Cr (FY 2025)); Girdhar Pharmaceuticals Private Limited (Director, since 01 Feb 2018, revenue ₹30,000 (FY 2025)); Divri Health And Education Llp (Partner, since 24 Jan 2026); Drms Agrotech Llp (Partner, since 21 Mar 2025); Drms Hospital Private Limited (Director, since 31 Mar 2022); and 1 more.

Suman Agarwal was first appointed on 03 May 2016 as Director at Vee Pee And Associate Pvt Ltd. The most recent appointment on record is 24 Jan 2026 at Divri Health And Education Llp.

The 2 current companies of Suman Agarwal that report revenue have a combined latest revenue of ₹22.19 Cr: Chandra Laxmi Hospital Private Limited ₹22.19 Cr (FY 2025); Girdhar Pharmaceuticals Private Limited ₹30,000 (FY 2025).

Suman Agarwal held 2 earlier board appointments: Deepnidhi Medicare Private Limited (Director, 11 Jan 2019 to 23 Feb 2021); Vee Pee And Associate Pvt Ltd (Director, 03 May 2016 to 27 Dec 2017).

The current boards of Suman Agarwal's companies include Divyansh Agarwal (Chandra Laxmi Hospital Private Limited), Mukesh Kumar Agarwal (Chandra Laxmi Hospital Private Limited), Ritika Agrawal (Chandra Laxmi Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available